Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma

Anticancer Res. 2010 Sep;30(9):3313-9.

Abstract

Background/aim: To examine the presence of macrophage migration inhibitory factor (MIF) quantitatively in relation to neoplastic progression of hypopharyngeal squamous cell carcinoma (HSCC).

Materials and methods: The presence of MIF was analysed by quantitative immunohistochemistry in sections of 81 HSCCs, and compared to 15 specimens of tumour-free epithelia (TF_E), 29 low-grade dysplasias (Low_D) and 25 high-grade dysplasias (High_D). In parallel, MIF expression was studied using Western blotting on a series of 19 fresh biopsies.

Results: A significant increase in MIF staining intensity (mean optical density) was observed in carcinoma samples compared to TF_E (p<10(-6)), Low_D (p=0.0006) or High_D (p=0.0006). Immunohistochemical MIF positivity was significantly higher in HSCCs than in TF_E (p=0.00001) or Low_D (p=0.001). The percentage of MIF-immunopositive cells (labelling index) significantly decreased in parallel with an apparent loss of histological differentiation (p=0.003).

Conclusion: This study identified the presence of MIF as a parameter that positively correlates with neoplastic progression of HSCC and cell differentiation status.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / analysis*
  • Blotting, Western
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology*
  • Disease Progression
  • Female
  • Humans
  • Hypopharyngeal Neoplasms / metabolism
  • Hypopharyngeal Neoplasms / pathology*
  • Immunohistochemistry
  • Intramolecular Oxidoreductases / biosynthesis*
  • Macrophage Migration-Inhibitory Factors / biosynthesis*
  • Male
  • Middle Aged
  • Neoplasm Staging

Substances

  • Biomarkers, Tumor
  • Macrophage Migration-Inhibitory Factors
  • Intramolecular Oxidoreductases
  • MIF protein, human